Quidelortho Corp Revenue per Employee (QDEL), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Quidelortho Corp  (NASDAQ: QDEL)
 

Quidelortho's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Quidelortho's Revenue per employee fell on a trailing twelve month basis to $ 398,954, but the productivity of Quidelortho's employees remained above the company average.
Within the Healthcare sector Employees of 231 other companies have achieved higher revenue per employee. While Quidelortho's total ranking has deteriorated compared to the previous quarter from 1274 to 1893. Quidelortho has 6,500 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

QDEL Revenue per Employee (Sep 27 2026)
III. Quarter		 (Jun 28 2026)
II. Quarter		 (Mar 29 2026)
I. Quarter		 (Dec 28 2025)
IV. Quarter		 (Sep 28 2025)
III. Quarter
Y / Y Revenue Change -11.57 % 2.77 % -10.54 % 2.23 % -3.74 %
Sales per Employee (TTM) $ 398,954 411,415 408,800 420,031 417,600
QDEL's Total Ranking # 1893 # 1274 # 866 # 1179 #
Seq. Revenue Change -1.9 % 1.79 % -14.34 % 3.39 % 14.01 %

QDEL Company Profile >> Back to QDEL Efficiency Comparisons >> Compare QDEL Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 2
Healthcare Sector # 232
Overall Market # 1893

Revenue per Employee Statistics
High Average Low
$ 502,462 $ 206,487 $ 24,397
(Jan 01 2023)   (Jun 30 2014)



Financial Statements
Quidelortho's Revenue MRQ $ 619 Millions Visit QDEL's Income Statement
Quidelortho's Revenues TTM $ 2,593 Millions Visit QDEL's aggregate revenue growth
What are QDEL's Sales? Visit QDEL's Sales by Segment




Other Ratios
Quidelortho's Income per Employee
Employees in In Vitro & In Vivo Diagnostic Substances
In Vitro & In Vivo Diagnostic Substances Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
QDEL's Revenue per Employee versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for QDEL's Competitors
Revenue per Employee for QDEL's Suppliers
Revenue per Employee for QDEL's Customers

You may also want to know
QDEL's Sales Growth Rates QDEL's Pe Price to earnings ratio QDEL's Receivables Turnover Ratio QDEL's Stock Quote
QDEL's Net Income Growth Rates QDEL's Ps Price to Sales ratio QDEL's Sales per Employee QDEL's Asset Turnover Ratio
QDEL's Net Margin QDEL's Pb Price to Book ratio QDEL's Financial Strength Ratios QDEL's Dividend Payout Ratio
Date modified: 2026-11-06T13:06:08+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 27 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 27 2026Number of Employees Sep 27 2026
Ionis Pharmaceuticals Inc   684,801.00 $ 960.091  Million 1,402 
Rhythm Pharmaceuticals Inc   678,135.27 $ 280.748  Million 414 
Inspire Medical Systems inc   661,810.95 $ 882.194  Million 1,333 
Caredx Inc   650,190.85 $ 497.396  Million 765 
Koru Medical Systems Inc   633,862.01 $ 46.272  Million 73 
Organon and Co   611,100.00 $ 6,111.000  Million 10,000 
Bioventus Inc   609,707.29 $ 585.319  Million 960 
Si bone inc   590,928.19 $ 222.189  Million 376 
Coya Therapeutics Inc   586,128.13 $ 4.689  Million 8 
Butterfly Network Inc   562,340.91 $ 123.715  Million 220 
Carlsmed Inc   559,716.54 $ 71.084  Million 127 
Beone Medicines Ltd   550,523.25 $ 6,606.279  Million 12,000 
Novavax inc   549,598.13 $ 411.649  Million 749 
Henry Schein Inc   549,360.00 $ 13,734.000  Million 25,000 
Bausch Health Companies Inc   547,438.42 $ 11,113.000  Million 20,300 
Iradimed Corporation  538,192.16 $ 89.340  Million 166 
Glaukos Corp  528,660.88 $ 578.355  Million 1,094 
Alpha Pro Tech Ltd   527,967.48 $ 64.940  Million 123 
Orthofix Medical Inc   520,674.77 $ 835.683  Million 1,605 
Angiodynamics Inc   512,316.46 $ 323.784  Million 632 
Resmed Inc   505,115.57 $ 5,743.164  Million 11,370 
Cardiff Lexington Corporation  503,682.17 $ 9.066  Million 18 
Avantor Inc   491,525.93 $ 6,635.600  Million 13,500 
Gossamer Bio Inc   484,092.59 $ 78.423  Million 162 
Lexicon Pharmaceuticals Inc   475,765.43 $ 38.537  Million 81 
Stryker Corp  469,642.86 $ 26,300.000  Million 56,000 
Monte Rosa Therapeutics Inc   468,833.33 $ 70.325  Million 150 
Trisalus Life Sciences Inc   464,676.47 $ 47.397  Million 102 
Dexcom Inc   459,900.90 $ 5,104.900  Million 11,100 
Medpace Holdings Inc   457,804.03 $ 2,838.385  Million 6,200 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.